Cargando…

New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis

Development of lymphoproliferative disorders (LPDs) is one of the well-known life-threatening complications in rheumatoid arthritis (RA) patients. However, there is a lack of definitive conclusions regarding the role of Epstein-Barr virus (EBV) activity in RA initiation and progression, especially i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banko, Ana, Miljanovic, Danijela, Lazarevic, Ivana, Jeremic, Ivica, Despotovic, Aleksa, Grk, Milka, Cirkovic, Andja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781518/ https://www.ncbi.nlm.nih.gov/pubmed/35062319 http://dx.doi.org/10.3390/v14010115

Ejemplares similares

Markers of Epstein–Barr Virus Infection in Association with the Onset and Poor Control of Rheumatoid Arthritis: A Prospective Cohort Study
por: Miljanovic, Danijela, et al.
Publicado: (2023)

Uncovering the Role of Epstein–Barr Virus Infection Markers for Remission in Rheumatoid Arthritis
por: Banko, Ana, et al.
Publicado: (2023)

Association of IL10RA, IL10RB, and IL22RA Polymorphisms/Haplotypes with Susceptibility to and Clinical Manifestations of SLE
por: Grk, Milka, et al.
Publicado: (2023)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
por: Banko, Ana, et al.
Publicado: (2021)

Epstein–Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement
por: Miskovic, Rada, et al.
Publicado: (2023)

Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field
por: Banko, Ana, et al.
Publicado: (2023)

Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
por: Lazarevic, Ivana, et al.
Publicado: (2019)

Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas
por: Lazarevic, Ivana, et al.
Publicado: (2023)

Comparison and Sensitivity Evaluation of Three Different Commercial Real-Time Quantitative PCR Kits for SARS-CoV-2 Detection
por: Banko, Ana, et al.
Publicado: (2021)

Analysis of the Variability of Epstein-Barr Virus Genes in Infectious Mononucleosis: Investigation of the Potential Correlation with Biochemical Parameters of Hepatic Involvement
por: Banko, Ana, et al.
Publicado: (2016)

Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression
por: Banko, Ana V., et al.
Publicado: (2016)

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
por: Lazarevic, Ivana, et al.
Publicado: (2021)

Treatment Advances in EBV Related Lymphoproliferative Diseases
por: Lv, Kebing, et al.
Publicado: (2022)

The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units
por: Despotovic, Aleksa, et al.
Publicado: (2021)

Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV
por: Wang, Pin-Yi, et al.
Publicado: (2012)

EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood
por: Hong, Mineui, et al.
Publicado: (2013)

Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases
por: Kimura, Hiroshi, et al.
Publicado: (2019)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
por: Pálmason, Róbert, et al.
Publicado: (2015)

Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
por: Hui, Kwai Fung, et al.
Publicado: (2019)

Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
por: Sato, Yoshitaka
Publicado: (2018)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
por: Shindiapina, Polina, et al.
Publicado: (2020)

ADA2 deficiency complicated by EBV-driven lymphoproliferative disease
por: Staples, Emily, et al.
Publicado: (2020)

Post-transplant lymphoproliferative disorder: case report and review of susceptibility to EBV in the Scottish adult renal transplant pool
por: Selvarajah, Viknesh, et al.
Publicado: (2009)

Characteristic Histological Findings of Asymptomatic EBV-associated Lymphoproliferative Disorders in Tonsils
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2018)

HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case
por: Bülbül, Göksenil, et al.
Publicado: (2022)

New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2022)

The First Molecular Characterization of Serbian SARS-CoV-2 Isolates From a Unique Early Second Wave in Europe
por: Miljanovic, Danijela, et al.
Publicado: (2021)

Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
por: Tatfi, Moussab, et al.
Publicado: (2019)

The First Case of Concomitant Mycobacterium Genavense Lymphadenitis and EBV-Positive Lymphoproliferative Disorder
por: Ito, Yusuke, et al.
Publicado: (2020)

EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
por: Prem, Shruti, et al.
Publicado: (2019)

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man
Publicado: (1991)

P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases
por: Yoshimori, Mayumi, et al.
Publicado: (2015)

EBV-Associated Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis in a Patient with Severe Celiac Disease
por: Kinross-Wright, John Jacob, et al.
Publicado: (2018)

HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome
por: Bacha, Dhouha, et al.
Publicado: (2017)

Intestinal ulcers as an initial finding in EBV-associated lymphoproliferative disorder: A case report
por: Wang, Sizhu, et al.
Publicado: (2020)

Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease
por: Roncati, Luca, et al.
Publicado: (2020)

Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease
por: Ahmed, Elshafa Hassan, et al.
Publicado: (2021)

EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer–Cell Lymphoproliferative Diseases
por: Jin, Jin, et al.
Publicado: (2023)

Highlights: Focus on immunodeficiency-associated lymphoproliferative disorders: Current topics on other iatrogenic immunodeficiency-associated lymphoproliferative disorders and EBV-positive mucocutaneous ulcer
por: Sato, Yasuharu
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ilqgj70l07hsj8raoti85q05l